CIDETTE PERRIN

Hospital outpatient department reimbursement - Advocated for legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement (H.R. 1314)to be grandfathered in under previous outpatient reimbursement rules. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement in hospital settings. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills and ongoing discussions in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

Hospital outpatient department reimbursement - Advocated for legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement (H.R. 1314)to be grandfathered in under previous outpatient reimbursement rules. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement in hospital settings. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills and ongoing discussions in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

Hospital outpatient department reimbursement (H.R. 5273 - The Helping Hospitals Improve Patient Care Act) - Supported passage of legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement to be grandfathered in under previous outpatient reimbursement rules, make modifications to the Medicare hospital readmissions reduction program, and other changes. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement for services delivered in a hospital setting. Medicare Total Quality Hospital Star Ratings - Advocated for a delay in the release of the new star ratings until the changes were made to the proposed methodology. Medicare Part B Drug Demonstration - Monitored the proposed demonstration and the impact it may have on hospitals. Tracked Congressional activity reviewing the proposal and legislation (H.R. 5122) to prevent CMS from moving forward with the demonstration.

Hospital outpatient department reimbursement (H.R. 5273 - The Helping Hospitals Improve Patient Care Act) - Supported passage of legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement to be grandfathered in under previous outpatient reimbursement rules, make modifications to the Medicare hospital readmissions reduction program, and other changes. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement for services delivered in a hospital setting. Medicare Total Quality Hospital Star Ratings - Advocated for a delay in the release of the new star ratings until the changes were made to the proposed methodology. Medicare Part B Drug Demonstration - Monitored the proposed demonstration and the impact it may have on hospitals. Tracked Congressional activity reviewing the proposal and legislation (H.R. 5122) to prevent CMS from moving forward with the demonstration.

Hospital Group Purchasing Organizations - Provided ongoing outreach and education efforts regarding the value delivered by group purchasing organizations for hospitals across the country. Meaningful Use of electronic health records - Raised concerns about the release of final Stage 3 meaningful user rules and tracked ongoing discussions around the future of the program 340B Drug Discount Program - Monitored proposals to modify the 340B Drug Discount program. 21st Century Cures (H.R. 6) - Monitored development of Senate counterpart to the House-passed 21st Century Cures legislation.

Hospital Group Purchasing Organizations - Provided ongoing outreach and education efforts regarding the value delivered by group purchasing organizations for hospitals across the country. Drug Prices - Tracked ongoing discussion and offered information relating to how hospital group purchasing organizations help hold down cost growth of prescription drugs. Monitored legislative proposals related to increasing prices in prescription drugs. 340B Drug Discount Program - Monitored proposals to modify the 340B Drug Discount program. 21st Century Cures (H.R. 6) - Tracked the development of Senate counterpart to the House-passed 21st Century Cures legislation and raised concerns about potential offsets that could impact hospital payments. Opioid legislation (S. 524, the Comprehensive Addiction and Recovery Act, House package including multiple bills) - Supported passage of legislation to address growing challenges related to opioid abuse and addiction. Zika Virus - Monitored ongoing debate around legislative packages to provide funding to combat the spread of the Zika Virus.

Hospital Group Purchasing Organizations - Provided ongoing outreach and education efforts regarding the value delivered by group purchasing organizations for hospitals across the country. Drug Prices - Tracked ongoing discussion and offered information relating to how hospital group purchasing organizations help hold down cost growth of prescription drugs. Monitored legislative proposals related to increasing prices in prescription drugs. 340B Drug Discount Program - Monitored proposals to modify the 340B Drug Discount program. 21st Century Cures (H.R. 6) - Tracked the development of Senate counterpart to the House-passed 21st Century Cures legislation and raised concerns about potential offsets that could impact hospital payments. Opioid legislation (S. 524, the Comprehensive Addiction and Recovery Act, House package including multiple bills) - Supported passage of legislation to address growing challenges related to opioid abuse and addiction. Zika Virus - Monitored ongoing debate around legislative packages to provide funding to combat the spread of the Zika Virus.

Hospital outpatient department reimbursement (H.R. 5273 - The Helping Hospitals Improve Patient Care Act) - Supported passage of legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement to be grandfathered in under previous outpatient reimbursement rules, make modifications to the Medicare hospital readmissions reduction program, and other changes. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement for services delivered in a hospital setting. Medicare Total Quality Hospital Star Ratings - Advocated for a delay in the release of the new star ratings until the changes were made to the proposed methodology. Medicare Part B Drug Demonstration - Monitored the proposed demonstration and the impact it may have on hospitals. Tracked Congressional activity reviewing the proposal and legislation (H.R. 5122) to prevent CMS from moving forward with the demonstration.

Hospital outpatient department reimbursement - Advocated for legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement (H.R. 1314)to be grandfathered in under previous outpatient reimbursement rules. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement in hospital settings. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills and ongoing discussions in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

Hospital Group Purchasing Organizations - conducted outreach and advocacy in support of hospital group purchasing organizations. Engaged in discussions related to GPO's role in preventing and addressing drug shortages and issues related to pharmacuetical distibution. Electronic Health Records Meaningful Use - Advocated that ONC and CMS focus on interoperability of EHR systems before advancing meaningful use requirements for stage three of the EHR incentive program. 21st Century Cures Act (H.R. 6) - Monitored the development of proposals related to hospitals and the 340B Drug discount program in the 21st Century Cures Act. Independent Payment Advisory Board (H.R. 1190, S.141) - Supported passage of legislation to repeal the Independent Payment Advisory Board.

H.R. 2 - Supported passage of H.R.2 to repeal the sustainable growth rate formula for Medicare physician reimbursement. Trade Adjustment Assistance (H.R. 1314) - Opposed inclusion of extension of sequestration cuts in TAA legislation. Medicare Audit Improvement Act (H.R. 2156) - Supported passage of HR 2156 to make modifications to the Medicare Recovery Audit Contractor Program. Physician-Owned Hospitals (H.R. 2513) - Opposed passage of H.R. 2513 which would repeal prohibitions on expanding or opening new physician owned hospitals. Medicare Hospital Readmissions Reduction Program (H.R. 1383, S. 688) - Supported passage of legislation that would incorporate sociodemographic status in determining readmissions penalties.

Debt Ceiling and Budget Agreement (H.R. 1314) - Opposed inclusion of provisions that extend Medicare sequestration and expressed opposition to a provision that reduces Medicare reimbursement for new off-campus hospital outpatient departments. Consolidated Appropriations Act (H.R. 2029) - Advocated for inclusion of provisions in year-end funding legislation that would allow under-construction hospital-affiliated outpatient departments to be grandfathered in under previous outpatient reimbursement rules. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Senate Finance Committee Chronic Care options - Monitored development of Senate Finance Committee's policy options for treating patients with chronic conditions. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

Medicare and Medicaid EHR incentive program meaningful use rules - urged CMS to release the final rules to provide flexibility for eligible hospitals and providers for 2015. Advocated that CMS consider delaying final meaningful use stage 3 rules until greater interoperability is achieved. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Comprehensive Care for Joint Replacement program - Tracked release of proposal to require mandatory payment bundling for hip and knee replacements in selected geographic regions across the country. Expressed concern about mandatory nature of the program and urged needed regulatory flexibility for hospitals. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - monitored release of three bills in the House Ways and Means Committee that would impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding. Hospital Two-midnight rule - advocated for extending enforcement delay on two-midnight rule to align timing with proposed regulatory delay through the end of 2015.

Debt Ceiling and Budget Agreement (H.R. 1314) - Opposed inclusion of provisions that extend Medicare sequestration and expressed opposition to a provision that reduces Medicare reimbursement for new off-campus hospital outpatient departments. Consolidated Appropriations Act (H.R. 2029) - Advocated for inclusion of provisions in year-end funding legislation that would allow under-construction hospital-affiliated outpatient departments to be grandfathered in under previous outpatient reimbursement rules. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Senate Finance Committee Chronic Care options - Monitored development of Senate Finance Committee's policy options for treating patients with chronic conditions. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

H.R. 2 - the Medicare and CHIP Reauthorization Act - Supported and advocated for passage of H.R. 2 to repeal the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed possible inclusion of hospital payment cuts. Medicare Hospital Readmissions Reduction Program - Monitored implementation of the Medicare hospital readmissions reduction program. Supported passage of legislation (H.R. 1343 and S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act) that would require CMS to include socio-demographic conditions in calculating penalties under the program. Hospital Two-midnight Rule - Advocated for continuing enforcement delay of the CMS' two-midnight rule for short stay hospital admissions. Supported similar provision in H.R. 2. Rural Hospital Legislation - Monitored legislation (H.R. 169, the Critical Access Hospital Relief Act and H.R. 170, the Rural Health Care Provider Relief Act) that would relieve regulatory burden on rural hospitals.

H.R. 2 - Supported passage of H.R.2 to repeal the sustainable growth rate formula for Medicare physician reimbursement. Trade Adjustment Assistance (H.R. 1314) - Opposed inclusion of extension of sequestration cuts in TAA legislation. Medicare Audit Improvement Act (H.R. 2156) - Supported passage of HR 2156 to make modifications to the Medicare Recovery Audit Contractor Program. Physician-Owned Hospitals (H.R. 2513) - Opposed passage of H.R. 2513 which would repeal prohibitions on expanding or opening new physician owned hospitals. Medicare Hospital Readmissions Reduction Program (H.R. 1383, S. 688) - Supported passage of legislation that would incorporate sociodemographic status in determining readmissions penalties.

H.R. 2 - the Medicare and CHIP Reauthorization Act - Supported and advocated for passage of H.R. 2 to repeal the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed possible inclusion of hospital payment cuts. Medicare Hospital Readmissions Reduction Program - Monitored implementation of the Medicare hospital readmissions reduction program. Supported passage of legislation (H.R. 1343 and S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act) that would require CMS to include socio-demographic conditions in calculating penalties under the program. Hospital Two-midnight Rule - Advocated for continuing enforcement delay of the CMS' two-midnight rule for short stay hospital admissions. Supported similar provision in H.R. 2. Rural Hospital Legislation - Monitored legislation (H.R. 169, the Critical Access Hospital Relief Act and H.R. 170, the Rural Health Care Provider Relief Act) that would relieve regulatory burden on rural hospitals.

H.R. 2 - the Medicare and CHIP Reauthorization Act - Supported and advocated for passage of H.R. 2 to repeal the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed possible inclusion of hospital payment cuts. Medicare Hospital Readmissions Reduction Program - Monitored implementation of the Medicare hospital readmissions reduction program. Supported passage of legislation (H.R. 1343 and S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act) that would require CMS to include socio-demographic conditions in calculating penalties under the program. Hospital Two-midnight Rule - Advocated for continuing enforcement delay of the CMS' two-midnight rule for short stay hospital admissions. Supported similar provision in H.R. 2. Rural Hospital Legislation - Monitored legislation (H.R. 169, the Critical Access Hospital Relief Act and H.R. 170, the Rural Health Care Provider Relief Act) that would relieve regulatory burden on rural hospitals.

H.R. 2 - Supported passage of H.R.2 to repeal the sustainable growth rate formula for Medicare physician reimbursement. Trade Adjustment Assistance (H.R. 1314) - Opposed inclusion of extension of sequestration cuts in TAA legislation. Medicare Audit Improvement Act (H.R. 2156) - Supported passage of HR 2156 to make modifications to the Medicare Recovery Audit Contractor Program. Physician-Owned Hospitals (H.R. 2513) - Opposed passage of H.R. 2513 which would repeal prohibitions on expanding or opening new physician owned hospitals. Medicare Hospital Readmissions Reduction Program (H.R. 1383, S. 688) - Supported passage of legislation that would incorporate sociodemographic status in determining readmissions penalties.

H.R. 2 - the Medicare and CHIP Reauthorization Act - Supported and advocated for passage of H.R. 2 to repeal the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed possible inclusion of hospital payment cuts. Medicare Hospital Readmissions Reduction Program - Monitored implementation of the Medicare hospital readmissions reduction program. Supported passage of legislation (H.R. 1343 and S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act) that would require CMS to include socio-demographic conditions in calculating penalties under the program. Hospital Two-midnight Rule - Advocated for continuing enforcement delay of the CMS' two-midnight rule for short stay hospital admissions. Supported similar provision in H.R. 2. Rural Hospital Legislation - Monitored legislation (H.R. 169, the Critical Access Hospital Relief Act and H.R. 170, the Rural Health Care Provider Relief Act) that would relieve regulatory burden on rural hospitals.

Hospital Group Purchasing Organizations - Provided ongoing outreach and education efforts regarding the benefit of group purchasing for hospitals across the country. Budget Reconciliation (H.R. 3762) - Tracked passage of budget reconciliation proposals aimed at repealing elements of the Affordable Care Act. Consolidated Appropriations Act (H.R. 2029) - Monitored passage of H.R. 2029 with provisions that make changes to the Affordable Care Act. Meaningful Use of electronic health records - Raised concerns about the release of final Stage 3 meaningful user rules. 340B Drug Discount Program - Monitored proposals to modify the 340B Drug Discount program. 21st Century Cures (H.R. 6) - Monitored development of Senate counterpart to the House-passed 21st Century Cures legislation. Health Insurance Mergers - Tracked House and Senate committee action related to anti-competitive impacts of mergers between large private health insurers.

Debt Ceiling and Budget Agreement (H.R. 1314) - Opposed inclusion of provisions that extend Medicare sequestration and expressed opposition to a provision that reduces Medicare reimbursement for new off-campus hospital outpatient departments. Consolidated Appropriations Act (H.R. 2029) - Advocated for inclusion of provisions in year-end funding legislation that would allow under-construction hospital-affiliated outpatient departments to be grandfathered in under previous outpatient reimbursement rules. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Senate Finance Committee Chronic Care options - Monitored development of Senate Finance Committee's policy options for treating patients with chronic conditions. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

H.R. 2 - Supported passage of H.R.2 to repeal the sustainable growth rate formula for Medicare physician reimbursement. Trade Adjustment Assistance (H.R. 1314) - Opposed inclusion of extension of sequestration cuts in TAA legislation. Medicare Audit Improvement Act (H.R. 2156) - Supported passage of HR 2156 to make modifications to the Medicare Recovery Audit Contractor Program. Physician-Owned Hospitals (H.R. 2513) - Opposed passage of H.R. 2513 which would repeal prohibitions on expanding or opening new physician owned hospitals. Medicare Hospital Readmissions Reduction Program (H.R. 1383, S. 688) - Supported passage of legislation that would incorporate sociodemographic status in determining readmissions penalties.

H.R. 2 - Supported passage of H.R.2 to repeal the sustainable growth rate formula for Medicare physician reimbursement. Trade Adjustment Assistance (H.R. 1314) - Opposed inclusion of extension of sequestration cuts in TAA legislation. Medicare Audit Improvement Act (H.R. 2156) - Supported passage of HR 2156 to make modifications to the Medicare Recovery Audit Contractor Program. Physician-Owned Hospitals (H.R. 2513) - Opposed passage of H.R. 2513 which would repeal prohibitions on expanding or opening new physician owned hospitals. Medicare Hospital Readmissions Reduction Program (H.R. 1383, S. 688) - Supported passage of legislation that would incorporate sociodemographic status in determining readmissions penalties.

Debt Ceiling and Budget Agreement (H.R. 1314) - Opposed inclusion of provisions that extend Medicare sequestration and expressed opposition to a provision that reduces Medicare reimbursement for new off-campus hospital outpatient departments. Consolidated Appropriations Act (H.R. 2029) - Advocated for inclusion of provisions in year-end funding legislation that would allow under-construction hospital-affiliated outpatient departments to be grandfathered in under previous outpatient reimbursement rules. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Senate Finance Committee Chronic Care options - Monitored development of Senate Finance Committee's policy options for treating patients with chronic conditions. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

Medicare and Medicaid EHR incentive program meaningful use rules - urged CMS to release the final rules to provide flexibility for eligible hospitals and providers for 2015. Advocated that CMS consider delaying final meaningful use stage 3 rules until greater interoperability is achieved. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Comprehensive Care for Joint Replacement program - Tracked release of proposal to require mandatory payment bundling for hip and knee replacements in selected geographic regions across the country. Expressed concern about mandatory nature of the program and urged needed regulatory flexibility for hospitals. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - monitored release of three bills in the House Ways and Means Committee that would impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding. Hospital Two-midnight rule - advocated for extending enforcement delay on two-midnight rule to align timing with proposed regulatory delay through the end of 2015.

Medicare and Medicaid EHR incentive program meaningful use rules - urged CMS to release the final rules to provide flexibility for eligible hospitals and providers for 2015. Advocated that CMS consider delaying final meaningful use stage 3 rules until greater interoperability is achieved. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Comprehensive Care for Joint Replacement program - Tracked release of proposal to require mandatory payment bundling for hip and knee replacements in selected geographic regions across the country. Expressed concern about mandatory nature of the program and urged needed regulatory flexibility for hospitals. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - monitored release of three bills in the House Ways and Means Committee that would impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding. Hospital Two-midnight rule - advocated for extending enforcement delay on two-midnight rule to align timing with proposed regulatory delay through the end of 2015.

Debt Ceiling and Budget Agreement (H.R. 1314) - Opposed inclusion of provisions that extend Medicare sequestration and expressed opposition to a provision that reduces Medicare reimbursement for new off-campus hospital outpatient departments. Consolidated Appropriations Act (H.R. 2029) - Advocated for inclusion of provisions in year-end funding legislation that would allow under-construction hospital-affiliated outpatient departments to be grandfathered in under previous outpatient reimbursement rules. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Senate Finance Committee Chronic Care options - Monitored development of Senate Finance Committee's policy options for treating patients with chronic conditions. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

Medicare and Medicaid EHR incentive program meaningful use rules - urged CMS to release the final rules to provide flexibility for eligible hospitals and providers for 2015. Advocated that CMS consider delaying final meaningful use stage 3 rules until greater interoperability is achieved. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Comprehensive Care for Joint Replacement program - Tracked release of proposal to require mandatory payment bundling for hip and knee replacements in selected geographic regions across the country. Expressed concern about mandatory nature of the program and urged needed regulatory flexibility for hospitals. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - monitored release of three bills in the House Ways and Means Committee that would impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding. Hospital Two-midnight rule - advocated for extending enforcement delay on two-midnight rule to align timing with proposed regulatory delay through the end of 2015.

Debt Ceiling and Budget Agreement (H.R. 1314) - Opposed inclusion of provisions that extend Medicare sequestration and expressed opposition to a provision that reduces Medicare reimbursement for new off-campus hospital outpatient departments. Consolidated Appropriations Act (H.R. 2029) - Advocated for inclusion of provisions in year-end funding legislation that would allow under-construction hospital-affiliated outpatient departments to be grandfathered in under previous outpatient reimbursement rules. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Senate Finance Committee Chronic Care options - Monitored development of Senate Finance Committee's policy options for treating patients with chronic conditions. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

Hospital Group Purchasing Organizations - Provided ongoing outreach and education efforts regarding the benefit of group purchasing for hospitals across the country. Budget Reconciliation (H.R. 3762) - Tracked passage of budget reconciliation proposals aimed at repealing elements of the Affordable Care Act. Consolidated Appropriations Act (H.R. 2029) - Monitored passage of H.R. 2029 with provisions that make changes to the Affordable Care Act. Meaningful Use of electronic health records - Raised concerns about the release of final Stage 3 meaningful user rules. 340B Drug Discount Program - Monitored proposals to modify the 340B Drug Discount program. 21st Century Cures (H.R. 6) - Monitored development of Senate counterpart to the House-passed 21st Century Cures legislation. Health Insurance Mergers - Tracked House and Senate committee action related to anti-competitive impacts of mergers between large private health insurers.

Hospital Group Purchasing Organizations - Provided ongoing outreach and education efforts regarding the benefit of group purchasing for hospitals across the country. Budget Reconciliation (H.R. 3762) - Tracked passage of budget reconciliation proposals aimed at repealing elements of the Affordable Care Act. Consolidated Appropriations Act (H.R. 2029) - Monitored passage of H.R. 2029 with provisions that make changes to the Affordable Care Act. Meaningful Use of electronic health records - Raised concerns about the release of final Stage 3 meaningful user rules. 340B Drug Discount Program - Monitored proposals to modify the 340B Drug Discount program. 21st Century Cures (H.R. 6) - Monitored development of Senate counterpart to the House-passed 21st Century Cures legislation. Health Insurance Mergers - Tracked House and Senate committee action related to anti-competitive impacts of mergers between large private health insurers.

Hospital Group Purchasing Organizations - Provided ongoing outreach and education efforts regarding the benefit of group purchasing for hospitals across the country. Budget Reconciliation - tracked budget reconciliation proposals aimed at repealing elements of the Affordable Care Act. 340B Drug Discount Program - monitored and provided information related to proposals to modify and provide additional guidance around the 340B Drug Discount program. 21st Century Cures (H.R. 6) - monitored development and passage in the House of Representatives of the 21st Century Cures legislation. Health Insurance Mergers - tracked House and Senate committee action related to anti-competitive impacts of mergers between large private health insurers.

Hospital Group Purchasing Organizations - conducted outreach and advocacy in support of hospital group purchasing organizations. Engaged in discussions related to GPO's role in preventing and addressing drug shortages and issues related to pharmacuetical distibution. Electronic Health Records Meaningful Use - Advocated that ONC and CMS focus on interoperability of EHR systems before advancing meaningful use requirements for stage three of the EHR incentive program. 21st Century Cures Act (H.R. 6) - Monitored the development of proposals related to hospitals and the 340B Drug discount program in the 21st Century Cures Act. Independent Payment Advisory Board (H.R. 1190, S.141) - Supported passage of legislation to repeal the Independent Payment Advisory Board.

Hospital Group Purchasing Organizations - conducted outreach and advocacy in support of hospital group purchasing organizations. Engaged in discussions related to GPO's role in preventing and addressing drug shortages and issues related to pharmacuetical distibution. Electronic Health Records Meaningful Use - Advocated that ONC and CMS focus on interoperability of EHR systems before advancing meaningful use requirements for stage three of the EHR incentive program. 21st Century Cures Act (H.R. 6) - Monitored the development of proposals related to hospitals and the 340B Drug discount program in the 21st Century Cures Act. Independent Payment Advisory Board (H.R. 1190, S.141) - Supported passage of legislation to repeal the Independent Payment Advisory Board.

Medicare and Medicaid EHR incentive program meaningful use rules - urged CMS to release the final rules to provide flexibility for eligible hospitals and providers for 2015. Advocated that CMS consider delaying final meaningful use stage 3 rules until greater interoperability is achieved. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Comprehensive Care for Joint Replacement program - Tracked release of proposal to require mandatory payment bundling for hip and knee replacements in selected geographic regions across the country. Expressed concern about mandatory nature of the program and urged needed regulatory flexibility for hospitals. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - monitored release of three bills in the House Ways and Means Committee that would impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding. Hospital Two-midnight rule - advocated for extending enforcement delay on two-midnight rule to align timing with proposed regulatory delay through the end of 2015.

Debt Ceiling and Budget Agreement (H.R. 1314) - Opposed inclusion of provisions that extend Medicare sequestration and expressed opposition to a provision that reduces Medicare reimbursement for new off-campus hospital outpatient departments. Consolidated Appropriations Act (H.R. 2029) - Advocated for inclusion of provisions in year-end funding legislation that would allow under-construction hospital-affiliated outpatient departments to be grandfathered in under previous outpatient reimbursement rules. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Senate Finance Committee Chronic Care options - Monitored development of Senate Finance Committee's policy options for treating patients with chronic conditions. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.

H.R. 2 - the Medicare and CHIP Reauthorization Act - Supported and advocated for passage of H.R. 2 to repeal the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed possible inclusion of hospital payment cuts. Medicare Hospital Readmissions Reduction Program - Monitored implementation of the Medicare hospital readmissions reduction program. Supported passage of legislation (H.R. 1343 and S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act) that would require CMS to include socio-demographic conditions in calculating penalties under the program. Hospital Two-midnight Rule - Advocated for continuing enforcement delay of the CMS' two-midnight rule for short stay hospital admissions. Supported similar provision in H.R. 2. Rural Hospital Legislation - Monitored legislation (H.R. 169, the Critical Access Hospital Relief Act and H.R. 170, the Rural Health Care Provider Relief Act) that would relieve regulatory burden on rural hospitals.

H.R. 2 - Supported passage of H.R.2 to repeal the sustainable growth rate formula for Medicare physician reimbursement. Trade Adjustment Assistance (H.R. 1314) - Opposed inclusion of extension of sequestration cuts in TAA legislation. Medicare Audit Improvement Act (H.R. 2156) - Supported passage of HR 2156 to make modifications to the Medicare Recovery Audit Contractor Program. Physician-Owned Hospitals (H.R. 2513) - Opposed passage of H.R. 2513 which would repeal prohibitions on expanding or opening new physician owned hospitals. Medicare Hospital Readmissions Reduction Program (H.R. 1383, S. 688) - Supported passage of legislation that would incorporate sociodemographic status in determining readmissions penalties.

Supported the Senate confirmation of Sylvia Mathews Burwell to be the Secretary of Health and Human Services. Monitored the proposed health policy and funding changes included in the House Budget Resolution (H.Con. Res. 96). 340B Drug Discount Programs - Engaged in monitoring ongoing discussions about the program and possible regulatory changes in light of legal activity challenging newly-eligible providers allowed by the Affordable Care Act.Hospital group purchasing organizations - conducted outreach and education efforts related to the value provided by hospital group purchasing organizations. Hospital pricing transparency - monitored legislative proposals (H.R. 1326, H.R. 2853 ) related to hospital pricing transparency.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Hospital Readmissions Reductions Program - Advocated in support of legislation (S. 2501, H.R. 4188) that would require CMS consider sociodemographic conditions in the hospital readmissions reduction program. Hospital two-midnights rule - Supported legislation (H.R. 3698, S. 2082) to delay implementation of the CMS' two-midnight rule and provide for stakeholder input in development of alternative payment models.Medicare physician payments - Monitored ongoing discussions to permanently repeal the sustainable growth rate formula. Recovery Audit Contractors - Supported legislation (H.R. 1250, S. 1012) that would place limits on collection activity by Medicare recovery audit contractors. Site-neutral payments - Monitored and expressed opposition to proposals that would equalize payments for certain treatments delivered in a hospital setting with treatments delivered in a physician's office.

Sustainable growth rate formula (H.R. 4015, S. 2157) - Advocated for the repeal of the SGR formula for Medicare physician reimbursement during the lame duck session of Congress. Opposed including further cuts to hospital payments to offset the cost of such legislation. Ways and Means Committee Hospital Improvement for Payment Discussion Draft - Monitored and reviewed the introduction of draft legislation from the Ways and Means Committee impacting hospital policies. Supported proposals to place greater restrictions on Medicare recovery audit contractor activities (similar to H.R. 1250, and S. 1012). Supported provision to include sociodemographic considerations in the Hospital Readmissions Reduction Program (similar to H.R. 4188 & S. 2501). Reviewed and monitored proposals to modify hospital payment systems to more accurately pay for short-stay admissions and supported proposals to delay enforcement of CMS' "two-midnight rule". Opposed provision that would relax current restrictions on physician-owned hospitals.

Supported the Senate confirmation of Sylvia Mathews Burwell to be the Secretary of Health and Human Services. Monitored the proposed health policy and funding changes included in the House Budget Resolution (H.Con. Res. 96). 340B Drug Discount Programs - Engaged in monitoring ongoing discussions about the program and possible regulatory changes in light of legal activity challenging newly-eligible providers allowed by the Affordable Care Act.Hospital group purchasing organizations - conducted outreach and education efforts related to the value provided by hospital group purchasing organizations. Hospital pricing transparency - monitored legislative proposals (H.R. 1326, H.R. 2853 ) related to hospital pricing transparency.

Supported the Senate confirmation of Sylvia Mathews Burwell to be the Secretary of Health and Human Services. Monitored the proposed health policy and funding changes included in the House Budget Resolution (H.Con. Res. 96). 340B Drug Discount Programs - Engaged in monitoring ongoing discussions about the program and possible regulatory changes in light of legal activity challenging newly-eligible providers allowed by the Affordable Care Act.Hospital group purchasing organizations - conducted outreach and education efforts related to the value provided by hospital group purchasing organizations. Hospital pricing transparency - monitored legislative proposals (H.R. 1326, H.R. 2853 ) related to hospital pricing transparency.

Hospital Readmissions Reductions Program - Advocated in support of legislation (S. 2501, H.R. 4188) that would require CMS consider sociodemographic conditions in the hospital readmissions reduction program. Hospital two-midnights rule - Supported legislation (H.R. 3698, S. 2082) to delay implementation of the CMS' two-midnight rule and provide for stakeholder input in development of alternative payment models.Medicare physician payments - Monitored ongoing discussions to permanently repeal the sustainable growth rate formula. Recovery Audit Contractors - Supported legislation (H.R. 1250, S. 1012) that would place limits on collection activity by Medicare recovery audit contractors. Site-neutral payments - Monitored and expressed opposition to proposals that would equalize payments for certain treatments delivered in a hospital setting with treatments delivered in a physician's office.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Sustainable growth rate formula (H.R. 4015, S. 2157) - Advocated for the repeal of the SGR formula for Medicare physician reimbursement during the lame duck session of Congress. Opposed including further cuts to hospital payments to offset the cost of such legislation. Ways and Means Committee Hospital Improvement for Payment Discussion Draft - Monitored and reviewed the introduction of draft legislation from the Ways and Means Committee impacting hospital policies. Supported proposals to place greater restrictions on Medicare recovery audit contractor activities (similar to H.R. 1250, and S. 1012). Supported provision to include sociodemographic considerations in the Hospital Readmissions Reduction Program (similar to H.R. 4188 & S. 2501). Reviewed and monitored proposals to modify hospital payment systems to more accurately pay for short-stay admissions and supported proposals to delay enforcement of CMS' "two-midnight rule". Opposed provision that would relax current restrictions on physician-owned hospitals.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Medicare Physician Payments - (S. 2011, H.R. 4302) Supported legislation to permanently repeal the sustainable growth rate formula. Opposed use of hospital payments as an offset. Supported inclusion of additional delays for two-midnight rule. Opposed efforts to include extension of sequestration Medicare payment cuts to hospitals as an offset for legislation to extend unemployment insurance, legislation to increase the debt ceiling and legislation to change COLA adjustments for military retirees.Hospital Two-Midnight Rule - Advocated for correcting policy and delaying implementation of CMS' two-midnight rule for hospital admissions. Supported legislation (S. 2082) to delay implementation of the rule, and develop new payment methodology for short inpatient admissions. Hospital Readmissions Reduction Program - Supported legislation (H.R. 4188) to make changes to the Medicare hospital readmissions reduction program.

Hospital Readmissions Reductions Program - Advocated in support of legislation (S. 2501, H.R. 4188) that would require CMS consider sociodemographic conditions in the hospital readmissions reduction program. Hospital two-midnights rule - Supported legislation (H.R. 3698, S. 2082) to delay implementation of the CMS' two-midnight rule and provide for stakeholder input in development of alternative payment models.Medicare physician payments - Monitored ongoing discussions to permanently repeal the sustainable growth rate formula. Recovery Audit Contractors - Supported legislation (H.R. 1250, S. 1012) that would place limits on collection activity by Medicare recovery audit contractors. Site-neutral payments - Monitored and expressed opposition to proposals that would equalize payments for certain treatments delivered in a hospital setting with treatments delivered in a physician's office.

Sustainable growth rate formula (H.R. 4015, S. 2157) - Advocated for the repeal of the SGR formula for Medicare physician reimbursement during the lame duck session of Congress. Opposed including further cuts to hospital payments to offset the cost of such legislation. Ways and Means Committee Hospital Improvement for Payment Discussion Draft - Monitored and reviewed the introduction of draft legislation from the Ways and Means Committee impacting hospital policies. Supported proposals to place greater restrictions on Medicare recovery audit contractor activities (similar to H.R. 1250, and S. 1012). Supported provision to include sociodemographic considerations in the Hospital Readmissions Reduction Program (similar to H.R. 4188 & S. 2501). Reviewed and monitored proposals to modify hospital payment systems to more accurately pay for short-stay admissions and supported proposals to delay enforcement of CMS' "two-midnight rule". Opposed provision that would relax current restrictions on physician-owned hospitals.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Medicare Physician Payments - (S. 2011, H.R. 4302) Supported legislation to permanently repeal the sustainable growth rate formula. Opposed use of hospital payments as an offset. Supported inclusion of additional delays for two-midnight rule. Opposed efforts to include extension of sequestration Medicare payment cuts to hospitals as an offset for legislation to extend unemployment insurance, legislation to increase the debt ceiling and legislation to change COLA adjustments for military retirees.Hospital Two-Midnight Rule - Advocated for correcting policy and delaying implementation of CMS' two-midnight rule for hospital admissions. Supported legislation (S. 2082) to delay implementation of the rule, and develop new payment methodology for short inpatient admissions. Hospital Readmissions Reduction Program - Supported legislation (H.R. 4188) to make changes to the Medicare hospital readmissions reduction program.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Hospital Readmissions Reductions Program - Advocated in support of legislation (S. 2501, H.R. 4188) that would require CMS consider sociodemographic conditions in the hospital readmissions reduction program. Hospital two-midnights rule - Supported legislation (H.R. 3698, S. 2082) to delay implementation of the CMS' two-midnight rule and provide for stakeholder input in development of alternative payment models.Medicare physician payments - Monitored ongoing discussions to permanently repeal the sustainable growth rate formula. Recovery Audit Contractors - Supported legislation (H.R. 1250, S. 1012) that would place limits on collection activity by Medicare recovery audit contractors. Site-neutral payments - Monitored and expressed opposition to proposals that would equalize payments for certain treatments delivered in a hospital setting with treatments delivered in a physician's office.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Sustainable growth rate formula (H.R. 4015, S. 2157) - Advocated for the repeal of the SGR formula for Medicare physician reimbursement during the lame duck session of Congress. Opposed including further cuts to hospital payments to offset the cost of such legislation. Ways and Means Committee Hospital Improvement for Payment Discussion Draft - Monitored and reviewed the introduction of draft legislation from the Ways and Means Committee impacting hospital policies. Supported proposals to place greater restrictions on Medicare recovery audit contractor activities (similar to H.R. 1250, and S. 1012). Supported provision to include sociodemographic considerations in the Hospital Readmissions Reduction Program (similar to H.R. 4188 & S. 2501). Reviewed and monitored proposals to modify hospital payment systems to more accurately pay for short-stay admissions and supported proposals to delay enforcement of CMS' "two-midnight rule". Opposed provision that would relax current restrictions on physician-owned hospitals.

Medicare Physician Payments - (S. 2011, H.R. 4302) Supported legislation to permanently repeal the sustainable growth rate formula. Opposed use of hospital payments as an offset. Supported inclusion of additional delays for two-midnight rule. Opposed efforts to include extension of sequestration Medicare payment cuts to hospitals as an offset for legislation to extend unemployment insurance, legislation to increase the debt ceiling and legislation to change COLA adjustments for military retirees.Hospital Two-Midnight Rule - Advocated for correcting policy and delaying implementation of CMS' two-midnight rule for hospital admissions. Supported legislation (S. 2082) to delay implementation of the rule, and develop new payment methodology for short inpatient admissions. Hospital Readmissions Reduction Program - Supported legislation (H.R. 4188) to make changes to the Medicare hospital readmissions reduction program.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Medicare Physician Payments - (S. 2011, H.R. 4302) Supported legislation to permanently repeal the sustainable growth rate formula. Opposed use of hospital payments as an offset. Supported inclusion of additional delays for two-midnight rule. Opposed efforts to include extension of sequestration Medicare payment cuts to hospitals as an offset for legislation to extend unemployment insurance, legislation to increase the debt ceiling and legislation to change COLA adjustments for military retirees.Hospital Two-Midnight Rule - Advocated for correcting policy and delaying implementation of CMS' two-midnight rule for hospital admissions. Supported legislation (S. 2082) to delay implementation of the rule, and develop new payment methodology for short inpatient admissions. Hospital Readmissions Reduction Program - Supported legislation (H.R. 4188) to make changes to the Medicare hospital readmissions reduction program.

Hospital Readmissions Reductions Program - Advocated in support of legislation (S. 2501, H.R. 4188) that would require CMS consider sociodemographic conditions in the hospital readmissions reduction program. Hospital two-midnights rule - Supported legislation (H.R. 3698, S. 2082) to delay implementation of the CMS' two-midnight rule and provide for stakeholder input in development of alternative payment models.Medicare physician payments - Monitored ongoing discussions to permanently repeal the sustainable growth rate formula. Recovery Audit Contractors - Supported legislation (H.R. 1250, S. 1012) that would place limits on collection activity by Medicare recovery audit contractors. Site-neutral payments - Monitored and expressed opposition to proposals that would equalize payments for certain treatments delivered in a hospital setting with treatments delivered in a physician's office.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Sustainable growth rate formula (H.R. 4015, S. 2157) - Advocated for the repeal of the SGR formula for Medicare physician reimbursement during the lame duck session of Congress. Opposed including further cuts to hospital payments to offset the cost of such legislation. Ways and Means Committee Hospital Improvement for Payment Discussion Draft - Monitored and reviewed the introduction of draft legislation from the Ways and Means Committee impacting hospital policies. Supported proposals to place greater restrictions on Medicare recovery audit contractor activities (similar to H.R. 1250, and S. 1012). Supported provision to include sociodemographic considerations in the Hospital Readmissions Reduction Program (similar to H.R. 4188 & S. 2501). Reviewed and monitored proposals to modify hospital payment systems to more accurately pay for short-stay admissions and supported proposals to delay enforcement of CMS' "two-midnight rule". Opposed provision that would relax current restrictions on physician-owned hospitals.

Sustainable growth rate formula (H.R. 4015, S. 2157) - Advocated for the repeal of the SGR formula for Medicare physician reimbursement during the lame duck session of Congress. Opposed including further cuts to hospital payments to offset the cost of such legislation. Ways and Means Committee Hospital Improvement for Payment Discussion Draft - Monitored and reviewed the introduction of draft legislation from the Ways and Means Committee impacting hospital policies. Supported proposals to place greater restrictions on Medicare recovery audit contractor activities (similar to H.R. 1250, and S. 1012). Supported provision to include sociodemographic considerations in the Hospital Readmissions Reduction Program (similar to H.R. 4188 & S. 2501). Reviewed and monitored proposals to modify hospital payment systems to more accurately pay for short-stay admissions and supported proposals to delay enforcement of CMS' "two-midnight rule". Opposed provision that would relax current restrictions on physician-owned hospitals.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Hospital Readmissions Reductions Program - Advocated in support of legislation (S. 2501, H.R. 4188) that would require CMS consider sociodemographic conditions in the hospital readmissions reduction program. Hospital two-midnights rule - Supported legislation (H.R. 3698, S. 2082) to delay implementation of the CMS' two-midnight rule and provide for stakeholder input in development of alternative payment models.Medicare physician payments - Monitored ongoing discussions to permanently repeal the sustainable growth rate formula. Recovery Audit Contractors - Supported legislation (H.R. 1250, S. 1012) that would place limits on collection activity by Medicare recovery audit contractors. Site-neutral payments - Monitored and expressed opposition to proposals that would equalize payments for certain treatments delivered in a hospital setting with treatments delivered in a physician's office.

Medicare hospital readmissions reduction program - (S. 2501, H.R. 4188) - Supported legislation that would include socio-demographic factors in calculating penalties under the Medicare hospital readmissions reduction program. Medicare physician payments - (H.R. 4015, S. 2157) Advocated for repealing the sustainable growth rate formula for Medicare physician reimbursement without cutting hospital reimbursement to offset the cost of repeal legislation.Recovery Audit Contractors (H.R. 1250, S. 1012) - Supported legislation that would place limits on collection activity by Medicare recovery audit contractors. Hospital Two-midnight rule (H.R. 3698, S. 2082) - Supported legislation that would delay the implementation of the so-called "two-midnight rule" for short-stay admissions and provide an opportunity for stakeholder development of alternative policies. Post-Acute Care (H.R. 4994, S. 2553) - Monitored legislation that promotes greater collaboration across delivery settings between post-acute health care providers.

Medicare Audit Improvement Act (H.R. 1250, S. 1012) - Supported legislation that would make changes to the Medicare Recovery Audit Contractor Program. Opposed efforts to extend sequestration cuts in Medicare payments in October government funding and debt ceiling agreement. Supported efforts to replace sequestration cuts with targeted reductions.Medicare Two-midnight rule (H.R. 3698) Supported legislation to delay the Medicare "Two Midnights rule" and urged CMS to make changes to the policy. Medicare physician payments - (H.R. 2810, Senate Finance and House Ways and Means Committee drafts) - Monitored House and Senate proposals to replace the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed proposals to reduce hospital payments to offset the cost of replacing the SGR formula.

340 B drug discount program - Advocated for additional time for hospitals to comply with revised guidance on the GPO exclusion utilized by the program. Hospital group purchasing - Conducted outreach efforts to promote the value offered to hospitals by group purchasing organizations Compounding pharmacies - (S. 959) monitored legislation that would increase regulation on compounding pharmacies.Pharmaceutical supply-chain security and shortages of prescription drugs - (H.R. 1919, S. 957) - Monitored legislative development of House and Senate "Track and Trace" legislation. Unique device identification - Advocated for the release of the final rule implementing a unique device identification system for medical devices.

Budget Control Act - Advocated for a delay or repeal of Medicare sequestration cuts in the Budget Control Act. Hospital Disproportionate Share Payments - Supported legislation (H.R. 1920) that would delay mandated DSH cuts in the Affordable Care Act. Supported confirmation of Marilyn Tavenner to be Administrator of the Centers for Medicare and Medicaid Services.Sustainable growth rate formula (H.R.574, Senate Finance, House Energy and Commerce and House Ways and Means Committee drafts) - Monitored ongoing discussions to replace the sustainable growth rate formula for Medicare reimbursement for physicians. Advocated against further cuts to hospital payments in order to offset replacement costs.

Medicare Physician Payments (H.R. 2810) - Tracked legislative efforts to replace the sustainable growth rate formula for physician reimbursement. Opposed potential hospital cuts as a part of any legislation. Hospital Disproportionate Share Payments - Supported legislation (H.R. 1920) that would delay mandated DSH cuts in the Affordable Care Act.Hospital Inpatient Admission Guidance - Advocated for a delay in implementation of the so-called "two-midnight" rule related to inpatient admission in the FY2014 hospital inpatient payment rule.

Preventive Health Scoring Legislation (H.R. 2663, S. 1422) - Supported passage of legislation that would allow the Congressional Budget Office to conduct scores for long-term cost reductions associated with preventive health care efforts. Hospital Group Purchasing Organizations - Outreach and education efforts related to the value hospital GPOs provide to their members. Monitored ongoing investigations regarding GPOs and drug shortages.Unique Device Identification - Advocated for the release of the final rule establishing a unique device identification system for medical devices as required by the Food and Drug Administration Amendments Act of 2007. Compounding Pharmacies and Supply-chain Security (H.R. 3204, S. 959) - Tracked legislation in the House and Senate that would provide additional uniform regulations on compounding pharmacies and provide additional capabilities to track and trace medication through the supply-chain. 340B Drug Discount Program - Advocated for additional implementation time for hospitals to remain in compliance under new regulatory guidance for the 340B drug discount program.

Medicare Audit Improvement Act (H.R. 1250, S. 1012) - Supported legislation that would make changes to the Medicare Recovery Audit Contractor Program. Opposed efforts to extend sequestration cuts in Medicare payments in October government funding and debt ceiling agreement. Supported efforts to replace sequestration cuts with targeted reductions.Medicare Two-midnight rule (H.R. 3698) Supported legislation to delay the Medicare "Two Midnights rule" and urged CMS to make changes to the policy. Medicare physician payments - (H.R. 2810, Senate Finance and House Ways and Means Committee drafts) - Monitored House and Senate proposals to replace the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed proposals to reduce hospital payments to offset the cost of replacing the SGR formula.

Medicare Physician Payments (H.R. 2810) - Tracked legislative efforts to replace the sustainable growth rate formula for physician reimbursement. Opposed potential hospital cuts as a part of any legislation. Hospital Disproportionate Share Payments - Supported legislation (H.R. 1920) that would delay mandated DSH cuts in the Affordable Care Act.Hospital Inpatient Admission Guidance - Advocated for a delay in implementation of the so-called "two-midnight" rule related to inpatient admission in the FY2014 hospital inpatient payment rule.

Hospital Group Purchasing - Conducted outreach on the value that hospital GPOs provide to hospitals. Monitored and engaged ongoing reviews of GPO best practices. Monitored ongoing implementation of the Affordable Care Act and conducted outreach efforts on the law's impact on hospitals. 340B Drug Discount Program - Monitored efforts to expand 340B to inpatient facilities and tracked ongoing investigations.Compounding Pharmacies and Supply-chain Security (H.R. 3204, S. 959) - Tracked legislation in the House and Senate that would provide additional uniform regulations on compounding pharmacies and provide additional capabilities to track and trace medication through the supply-chain.

Preventive Health Scoring Legislation (H.R. 2663, S. 1422) - Supported passage of legislation that would allow the Congressional Budget Office to conduct scores for long-term cost reductions associated with preventive health care efforts. Hospital Group Purchasing Organizations - Outreach and education efforts related to the value hospital GPOs provide to their members. Monitored ongoing investigations regarding GPOs and drug shortages.Unique Device Identification - Advocated for the release of the final rule establishing a unique device identification system for medical devices as required by the Food and Drug Administration Amendments Act of 2007. Compounding Pharmacies and Supply-chain Security (H.R. 3204, S. 959) - Tracked legislation in the House and Senate that would provide additional uniform regulations on compounding pharmacies and provide additional capabilities to track and trace medication through the supply-chain. 340B Drug Discount Program - Advocated for additional implementation time for hospitals to remain in compliance under new regulatory guidance for the 340B drug discount program.

Medicare Audit Improvement Act (H.R. 1250, S. 1012) - Supported legislation that would make changes to the Medicare Recovery Audit Contractor Program. Opposed efforts to extend sequestration cuts in Medicare payments in October government funding and debt ceiling agreement. Supported efforts to replace sequestration cuts with targeted reductions.Medicare Two-midnight rule (H.R. 3698) Supported legislation to delay the Medicare "Two Midnights rule" and urged CMS to make changes to the policy. Medicare physician payments - (H.R. 2810, Senate Finance and House Ways and Means Committee drafts) - Monitored House and Senate proposals to replace the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed proposals to reduce hospital payments to offset the cost of replacing the SGR formula.

Sustainable Growth Rate Formula (H.R.574, Senate Finance, House Energy and Commerce and House Ways and Means Committee drafts) - monitored ongoing discussions to replace the sustainable growth rate formula for Medicare reimbursement for physicians. Advocated against further cuts to hospital payments in order to offset replacement costs. Budget Control Act - Urged Congress to pass legislation to avoid or delay sequestration Medicare reimbursement cuts for hospitals.

Budget Control Act - Advocated for a delay or repeal of Medicare sequestration cuts in the Budget Control Act. Hospital Disproportionate Share Payments - Supported legislation (H.R. 1920) that would delay mandated DSH cuts in the Affordable Care Act. Supported confirmation of Marilyn Tavenner to be Administrator of the Centers for Medicare and Medicaid Services.Sustainable growth rate formula (H.R.574, Senate Finance, House Energy and Commerce and House Ways and Means Committee drafts) - Monitored ongoing discussions to replace the sustainable growth rate formula for Medicare reimbursement for physicians. Advocated against further cuts to hospital payments in order to offset replacement costs.

Medicare Audit Improvement Act (H.R. 1250, S. 1012) - Supported legislation that would make changes to the Medicare Recovery Audit Contractor Program. Opposed efforts to extend sequestration cuts in Medicare payments in October government funding and debt ceiling agreement. Supported efforts to replace sequestration cuts with targeted reductions.Medicare Two-midnight rule (H.R. 3698) Supported legislation to delay the Medicare "Two Midnights rule" and urged CMS to make changes to the policy. Medicare physician payments - (H.R. 2810, Senate Finance and House Ways and Means Committee drafts) - Monitored House and Senate proposals to replace the sustainable growth rate formula for Medicare reimbursement for physicians. Opposed proposals to reduce hospital payments to offset the cost of replacing the SGR formula.

Preventive Health Scoring Legislation (H.R. 2663, S. 1422) - Supported passage of legislation that would allow the Congressional Budget Office to conduct scores for long-term cost reductions associated with preventive health care efforts. Hospital Group Purchasing Organizations - Outreach and education efforts related to the value hospital GPOs provide to their members. Monitored ongoing investigations regarding GPOs and drug shortages.Unique Device Identification - Advocated for the release of the final rule establishing a unique device identification system for medical devices as required by the Food and Drug Administration Amendments Act of 2007. Compounding Pharmacies and Supply-chain Security (H.R. 3204, S. 959) - Tracked legislation in the House and Senate that would provide additional uniform regulations on compounding pharmacies and provide additional capabilities to track and trace medication through the supply-chain. 340B Drug Discount Program - Advocated for additional implementation time for hospitals to remain in compliance under new regulatory guidance for the 340B drug discount program.

340 B drug discount program - Advocated for additional time for hospitals to comply with revised guidance on the GPO exclusion utilized by the program. Hospital group purchasing - Conducted outreach efforts to promote the value offered to hospitals by group purchasing organizations Compounding pharmacies - (S. 959) monitored legislation that would increase regulation on compounding pharmacies.Pharmaceutical supply-chain security and shortages of prescription drugs - (H.R. 1919, S. 957) - Monitored legislative development of House and Senate "Track and Trace" legislation. Unique device identification - Advocated for the release of the final rule implementing a unique device identification system for medical devices.

Preventive Health Scoring Legislation (H.R. 2663, S. 1422) - Supported passage of legislation that would allow the Congressional Budget Office to conduct scores for long-term cost reductions associated with preventive health care efforts. Hospital Group Purchasing Organizations - Outreach and education efforts related to the value hospital GPOs provide to their members. Monitored ongoing investigations regarding GPOs and drug shortages.Unique Device Identification - Advocated for the release of the final rule establishing a unique device identification system for medical devices as required by the Food and Drug Administration Amendments Act of 2007. Compounding Pharmacies and Supply-chain Security (H.R. 3204, S. 959) - Tracked legislation in the House and Senate that would provide additional uniform regulations on compounding pharmacies and provide additional capabilities to track and trace medication through the supply-chain. 340B Drug Discount Program - Advocated for additional implementation time for hospitals to remain in compliance under new regulatory guidance for the 340B drug discount program.

340 B drug discount program - Advocated for additional time for hospitals to comply with revised guidance on the GPO exclusion utilized by the program. Hospital group purchasing - Conducted outreach efforts to promote the value offered to hospitals by group purchasing organizations Compounding pharmacies - (S. 959) monitored legislation that would increase regulation on compounding pharmacies.Pharmaceutical supply-chain security and shortages of prescription drugs - (H.R. 1919, S. 957) - Monitored legislative development of House and Senate "Track and Trace" legislation. Unique device identification - Advocated for the release of the final rule implementing a unique device identification system for medical devices.

Hospital Group Purchasing - Conducted outreach on the value that hospital GPOs provide to hospitals. Monitored and engaged ongoing reviews of GPO best practices. Monitored ongoing implementation of the Affordable Care Act and conducted outreach efforts on the law's impact on hospitals. 340B Drug Discount Program - Monitored efforts to expand 340B to inpatient facilities and tracked ongoing investigations.Compounding Pharmacies and Supply-chain Security (H.R. 3204, S. 959) - Tracked legislation in the House and Senate that would provide additional uniform regulations on compounding pharmacies and provide additional capabilities to track and trace medication through the supply-chain.

Shortage of prescription drugs - Supported and tracked legislative efforts (S. 296, H.R 2245, Energy and Commerce and HELP Committee draft legislation) to mitigate ongoing issue with prescription drug shortages. Hospital Group Purchasing - Engaged in education and outreach efforts on hospital group purchasing organization and the role of GPOs play in the health care marketplace. Tracked implementation of transparancy efforts included under the Affordable Care Act. Unique Device Identification - Advocated for the release of regulations developing a unique device identification system for medical devices as required under the Food and Drug Administration Amendments Act of 2007. Endorsed legislation (S. 2193) that would require the FDA to issue such regulations by the end of 2012. 340 B (of the Public Health Services Act) Drug Discount Program - Monitored Congressional investigation into the 340 B drug discount program. Tracked legislative proposals to expand the program to inpatient hospitals. Independent Payment Advisory Board - Supported legislation (S. 668, H.R. 452) to repeal the Independent Payment Advisory Board. Tracked legislative efforts (H.R. 5) to repeal IPAB and make changes to medical malpractice laws. Conducted outreach and education efforts with policymakers on initiatives being offered by VHA to improve hospital clinical performance.

Hospital Group Purchasing - Engaged in outreach and education efforts to demonstrate the value that GPOs offer to hospitals. Budget Control Act - Advocated for changes to the Budget control act to prevent a 2.0% cut in Medicare payments for hospitals. Physician Payment Sunshine Act - tracked implementation of the Medicare physician payment sunshine requirements from the Affordable Care Act. 340 B (of the Public Health Services Act ) Drug Discount Program - tracked Congressional investigations of the 340B program and monitored legislative efforts (H.R. 2674) to expand the program to inpatient providers. Health IT - followed the continued implementation of the HITECH Act, and the health IT incentive program for meaningful users of electronic health records. Shortage of prescription drugs - monitored ongoing federal efforts to combat the shortage of prescription drugs. Advocated for proposals that would help ease the shortage in the Food and Drug Administration Safety and Innovation Act which was signed into law on July 9. Unique Device Identification - supported inclusion of provisions in the Food and Drug Administration Safety and Innovation Act requiring the FDA to implement a unique device identification system for medical devices by a set date.

Hospital Group Purchasing - Engaged in education and outreach efforts to promote the value of hospital group purchasing organizations for America's hospitals. Responded to inquiries about hospital utilization of compounding pharmacies and relation to group purchasing contracts. Tracked legislative efforts to expand FDA's authority to regulate large compounding pharmacies (H.R. 6584). Unique Device Identification - tracked the release of regulations from the FDA to establish a unique device identification system as required under the Food and Drug Administration Amendments Act of 2007. Urged a more aggressive timeline for implementation of a UDI system. 340 B of the Public Health Service Act Drug Discount Program - tracked legislative proposals to expand the 340B drug discount program to inpatient providers (H.R. 2674).

Shortage of Prescription Drugs - monitored legislative language in FDA user fee legislation that would combat shortages of prescription drugs. Supported inclusion of such language in final legislation. Unique Device Identification - advocated for inclusion of legislative language in FDA user fee legislation that would require the FDA to issue regulations to implement a national unique device identification system by the end of 2012. Hospital Group Purchasing - Engaged in education and outreach efforts to highlight the import role that hospital GPOs play in the health care marketplace. Tracked issues related to implementation of transparency efforts and assessment of the medical device tax included in the Affordable Care Act. 340 B (of the Public Health Services Act) Drug Discount Program - tracked Congressional investigation related to the 340B drug discount program. Monitored legislative efforts (H.R.2674) to make changes to the program. Engaged in outreach efforts to demonstrate innovative initiatives being offered by VHA to improve hospital clinical performance.

Shortage of prescription drugs - Supported and tracked legislative efforts (S. 296, H.R 2245, Energy and Commerce and HELP Committee draft legislation) to mitigate ongoing issue with prescription drug shortages. Hospital Group Purchasing - Engaged in education and outreach efforts on hospital group purchasing organization and the role of GPOs play in the health care marketplace. Tracked implementation of transparancy efforts included under the Affordable Care Act. Unique Device Identification - Advocated for the release of regulations developing a unique device identification system for medical devices as required under the Food and Drug Administration Amendments Act of 2007. Endorsed legislation (S. 2193) that would require the FDA to issue such regulations by the end of 2012. 340 B (of the Public Health Services Act) Drug Discount Program - Monitored Congressional investigation into the 340 B drug discount program. Tracked legislative proposals to expand the program to inpatient hospitals. Independent Payment Advisory Board - Supported legislation (S. 668, H.R. 452) to repeal the Independent Payment Advisory Board. Tracked legislative efforts (H.R. 5) to repeal IPAB and make changes to medical malpractice laws. Conducted outreach and education efforts with policymakers on initiatives being offered by VHA to improve hospital clinical performance.

H.R. 8 - Fiscal Cliff Legislation - Opposed additional cuts to hospital payments in negotiations to address the fiscal cliff. Supported delay or repeal of automatic Medicare cuts as a result of the Budget Control Act of 2011. Medicare Physician Reimbursement - Opposed inclusion of cuts to hospital reimbursement in negotiations to prevent Medicare cuts to physician reimbursement as a result of the statutory reductions from the Sustainable Growth Rate formula.

Shortage of prescription drugs - Supported and tracked legislative efforts (S. 296, H.R 2245, Energy and Commerce and HELP Committee draft legislation) to mitigate ongoing issue with prescription drug shortages. Hospital Group Purchasing - Engaged in education and outreach efforts on hospital group purchasing organization and the role of GPOs play in the health care marketplace. Tracked implementation of transparancy efforts included under the Affordable Care Act. Unique Device Identification - Advocated for the release of regulations developing a unique device identification system for medical devices as required under the Food and Drug Administration Amendments Act of 2007. Endorsed legislation (S. 2193) that would require the FDA to issue such regulations by the end of 2012. 340 B (of the Public Health Services Act) Drug Discount Program - Monitored Congressional investigation into the 340 B drug discount program. Tracked legislative proposals to expand the program to inpatient hospitals. Independent Payment Advisory Board - Supported legislation (S. 668, H.R. 452) to repeal the Independent Payment Advisory Board. Tracked legislative efforts (H.R. 5) to repeal IPAB and make changes to medical malpractice laws. Conducted outreach and education efforts with policymakers on initiatives being offered by VHA to improve hospital clinical performance.

Hospital Group Purchasing - Engaged in education and outreach efforts to promote the value of hospital group purchasing organizations for America's hospitals. Responded to inquiries about hospital utilization of compounding pharmacies and relation to group purchasing contracts. Tracked legislative efforts to expand FDA's authority to regulate large compounding pharmacies (H.R. 6584). Unique Device Identification - tracked the release of regulations from the FDA to establish a unique device identification system as required under the Food and Drug Administration Amendments Act of 2007. Urged a more aggressive timeline for implementation of a UDI system. 340 B of the Public Health Service Act Drug Discount Program - tracked legislative proposals to expand the 340B drug discount program to inpatient providers (H.R. 2674).

Shortage of prescription drugs - Supported and tracked legislative efforts (S. 296, H.R 2245, Energy and Commerce and HELP Committee draft legislation) to mitigate ongoing issue with prescription drug shortages. Hospital Group Purchasing - Engaged in education and outreach efforts on hospital group purchasing organization and the role of GPOs play in the health care marketplace. Tracked implementation of transparancy efforts included under the Affordable Care Act. Unique Device Identification - Advocated for the release of regulations developing a unique device identification system for medical devices as required under the Food and Drug Administration Amendments Act of 2007. Endorsed legislation (S. 2193) that would require the FDA to issue such regulations by the end of 2012. 340 B (of the Public Health Services Act) Drug Discount Program - Monitored Congressional investigation into the 340 B drug discount program. Tracked legislative proposals to expand the program to inpatient hospitals. Independent Payment Advisory Board - Supported legislation (S. 668, H.R. 452) to repeal the Independent Payment Advisory Board. Tracked legislative efforts (H.R. 5) to repeal IPAB and make changes to medical malpractice laws. Conducted outreach and education efforts with policymakers on initiatives being offered by VHA to improve hospital clinical performance.

Hospital Group Purchasing - Conducted outreach and education efforts on the value of group purchasing organizations for hospitals. Monitored and expressed support for draft proposals to create greater transparency in the pricing of medical devices. H.R. 5 - Monitored the legislative movement of Medical Liability reform legislation. Advocated for policies that would ease the burden of liability costs on health care providers and promote competition in the insurance marketplace. Unique Device Identification - Advocated for the release of FDA regulations to establish a unique device identification system for medical devices as required by the Food and Drug Administration Amendments Act of 2007. H.R. 2 - Monitored efforts to repeal the Patient Protection and Affordable Care Act. Advocated against eliminating expanded insurance coverage and wholesale changes, while encouraging an approach that would allow fixing pieces of the law while maintaining any improvements. S. 296 - Monitored legislation that would require drug manufacturers to report to the FDA on potential drug shortages. H.R. 452, S. 668 - Tracked the release of legislation that would repeal the Independent Payment Advisory Board created under the Patient Protection and Affordable Care Act. Patient Safety Initiative - monitored the release of a possible patient safety initiative from HHS. Engaged in policy discussions as to how VHA may be suited to engage policy makers in support of improving patient safety.